10
2020
-
09
Haizhi Biotech collaborates with Yunhe Pharmaceutical to promote the inheritance and innovation of traditional Chinese medicine.
The two founders of Jiangsu Haizhi Biotechnology were invited to visit Yunnan Yunhe Pharmaceutical Co., Ltd., where they received a warm welcome from Chairman Hu Songmou and his team members. Both parties have preliminarily reached a cooperation intention to focus on promoting the development and application of the national medicine dragon's blood resin resources.

2020Year8Month26-28On the 26th to 28th, the two founders of Jiangsu Haizhi Biotechnology were invited to visit Yunnan Yunhe Pharmaceutical Co., Ltd., where they received a warm welcome from Chairman Hu Songmou and his team members. Both parties preliminarily reached a cooperation intention to focus on promoting the development and application of the national medicine dragon's blood resources.

Yunhe Pharmaceutical is located in Gejiu City, Honghe Prefecture, Yunnan Province, relying on the unique natural medicinal treasure trove of Yunnan Province and the authentic natural medicinal resources of Southeast Asia, excavating the essence of traditional Chinese medicine and ethnic medicine secret prescriptions.After years of hard work, Yunhe Pharmaceuticalhas grown into a pillar of China's dragon's blood industry and is also a pioneer and leading enterprise in the ethnic medicine industry.

Chairman Hu Songmou of Yunhe Pharmaceutical has devoted his life to the research, protection, and development of dragon's blood resources. The most distinctive pharmacological effect of dragon's blood is its dual regulation of promoting blood circulation and stopping bleeding. Yang Zheng, founder and chief technology officer of Haizhi Biotechnology, said:"At the moment I saw the treasure of Yunhe Pharmaceutical, the 'Plant Longevity Star' dragon's blood tree, I was moved by the dedication and efforts of Yunhe employees who have rooted themselves in the development and utilization of national medicine dragon's blood for decades, striving to enhance the competitiveness of the ethnic medicine industry!"

To jointly promote the inheritance and innovation of ethnic medicine, Haizhi Biotechnology, based on its own technological advantages and in conjunction with its close technical cooperation with China Pharmaceutical University, has preliminarily reached cooperation intentions with Yunhe Pharmaceutical in three areas: first, dragon's blood liquid wound dressings./Liquid wound dressings; second, the development of external applications for the classic prescription Hu Li San capsules; third, the development of dragon's blood series cosmetics applied to freckle removal and anti-wrinkle./抗衰方向龙血竭系列化妆品开发。

9Month10Early in the morning on the day, Chairman Hu Songmou of Yunhe Pharmaceutical and his team members visited China Pharmaceutical University to meet with Professor Liu Jianping, chief scientist and expert in transdermal drug delivery at Haizhi Biotechnology, and together with the Haizhi R&D team, they deeply discussed the development and application of dragon's blood in wound care, oral care, and functional cosmetics, and determined the specific cooperation plan for the three parties' technology and related products, reaching a cooperation framework agreement.

Ethnic medicine is an important part of our country's traditional medicine and excellent ethnic culture, and it is a summary of the long-term struggle of all ethnic groups against diseases and a crystallization of wisdom. The development of ethnic medicine is not only an important medical and academic issue but also concerns respecting ethnic feelings, inheriting ethnic culture, enhancing ethnic unity, and promoting the overall prosperity of the nation.

Without good inheritance, innovation has no foundation.;Without good innovation, inheritance lacks motivation.Keep pace with the times and strive upward.By combining classic ethnic medicine prescriptions with modern technology, traditional ethnic medicine can shine with the brilliance of the times.
More news